149 related articles for article (PubMed ID: 33319736)
1. Case Report: Cutaneous Leishmaniasis Misdiagnosed as Pyoderma Gangrenosum.
Di Altobrando A; Misciali C; Raone B; Attard L; Gaspari V
Am J Trop Med Hyg; 2020 Dec; 104(2):640-642. PubMed ID: 33319736
[TBL] [Abstract][Full Text] [Related]
2. A pyoderma gangrenous-like cutaneous leishmaniasis in a Libyan woman with rheumatoid arthritis: a case report.
Al-Dwibe H; Amro A; Gashout A; El-Zurghany A; El-Zubi S; El-Hashme M; Hamarsheh O; Maree M
BMC Res Notes; 2018 Mar; 11(1):158. PubMed ID: 29490707
[TBL] [Abstract][Full Text] [Related]
3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
4. [Cutaneous leishmaniasis in a patient with ulcerative colitis under treatment with infliximab].
Fernández ML; Ramírez F; García E
Gastroenterol Hepatol; 2015 Nov; 38(9):564-5. PubMed ID: 25888288
[No Abstract] [Full Text] [Related]
5. [Pyoderma gangrenosum: case report].
Cavka V; Situm M; Poduje S; Brtan A; Mandusić N; Cubrilović Z
Acta Med Croatica; 2012 Oct; 66 Suppl 1():25-8. PubMed ID: 23193817
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series.
Phillips FM; Verstockt B; Sebastian S; Ribaldone D; Vavricka S; Katsanos K; Slattery E; de Suray N; Flores C; Fries W; Vincenzi F; Capoferro E; Bachmann O; Kopylov U
J Crohns Colitis; 2020 Oct; 14(10):1488-1493. PubMed ID: 32318735
[TBL] [Abstract][Full Text] [Related]
7. Crohn's disease of the penis masquerading as pyoderma gangrenosum: a case report and review of the literature.
Sams HH; Kiripolsky MG; Boyd AS; King LE
Cutis; 2003 Dec; 72(6):432-7. PubMed ID: 14700212
[TBL] [Abstract][Full Text] [Related]
8. Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences.
Juzlova K; Votrubova J; Kacerovska D; Lukas M; Bortlik M; Rohacova H; Nohynkova E; Vojackova N; Fialova J; Hercogova J
Dermatol Ther; 2014; 27(3):131-4. PubMed ID: 24903470
[TBL] [Abstract][Full Text] [Related]
9. A case report of cutaneous leishmaniasis: a misleading clinical presentation.
Vanlier C; Marot L; Laranaga E; D'abadie P; Yombi JC; Yildiz H; Baeck M
Infection; 2021 Feb; 49(1):177-180. PubMed ID: 32876896
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
[TBL] [Abstract][Full Text] [Related]
11. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
Carp JM; Onuma E; Das K; Gottlieb AB
Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
[TBL] [Abstract][Full Text] [Related]
12. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
[TBL] [Abstract][Full Text] [Related]
13. Pustular pyoderma gangrenosum: an uncommon variant which is easily misdiagnosed.
Chia MW; Teo L; Tay YK; Poh WT
Dermatol Online J; 2008 Feb; 14(2):21. PubMed ID: 18700124
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroid-resistant pyoderma gangrenosum associated with Crohn's disease: rapid cure with infliximab.
Grange F; Djilali-Bouzina F; Weiss AM; Polette A; Guillaume JC
Dermatology; 2002; 205(3):278-80. PubMed ID: 12399677
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Triple Combination Therapy for Recalcitrant Perineal Pyoderma Gangrenosum.
Shaath TS; Om A; Wolfe CM; Cohen GF
J Drugs Dermatol; 2019 Mar; 18(3):307-310. PubMed ID: 31020825
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.
Argüelles-Arias F; Castro-Laria L; Lobatón T; Aguas-Peris M; Rojas-Feria M; Barreiro-de Acosta M; Soto-Escribano P; Calvo-Moya M; Ginard-Vicens D; Chaparro-Sánchez M; Hernández-Durán M; Castro-Senosiain B; Fernández-Villaverde A; García-Sánchez V; Domínguez-Muñoz E; Caunedo-Álvarez A; Herrerías-Gutiérrez JM
Dig Dis Sci; 2013 Oct; 58(10):2949-54. PubMed ID: 23828140
[TBL] [Abstract][Full Text] [Related]
17. A RARE CASE OF CROHN DISEASE COMPLICATED WITH STEROID MONOTHERAPY-RELATED RETROPHARYNGEAL ABSCESS AND INITIALLY MISINTERPRETED PYODERMA GANGRENOSUM DEVELOPMENT.
Doulberis M; Dähn J; Kountouras J; Maier V; Helbling A; Dubach P
Gastroenterol Nurs; 2018; 41(4):347-351. PubMed ID: 30063691
[No Abstract] [Full Text] [Related]
18. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.
Darcis G; Van der Auwera G; Giot JB; Hayette MP; Tassin F; Arrese Estrada J; Cnops L; Moutschen M; de Leval L; Leonard P
BMC Infect Dis; 2017 Jul; 17(1):478. PubMed ID: 28687071
[TBL] [Abstract][Full Text] [Related]
19. Auricular pyoderma gangrenosum associated with Crohn's disease.
Ben Chaabane N; Hellara O; Ben Mansour W; Ben Mansour I; Melki W; Loghmeri H; Safer L; Bdioui F; Saffar H
Tunis Med; 2012 May; 90(5):414-5. PubMed ID: 22585655
[No Abstract] [Full Text] [Related]
20. Treatment of pyoderma gangrenosum with infliximab in Crohn's disease.
Sapienza MS; Cohen S; Dimarino AJ
Dig Dis Sci; 2004 Sep; 49(9):1454-7. PubMed ID: 15481318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
